中国药物经济学2016，Vol.11Issue(7)：10-13,4.DOI:10.12010/j.issn.1673-5846.2016.07.002
喹硫平与奥氮平治疗精神分裂症患者的疾病负担研究
Disease Burden Research of Quetiapine and Olanzapine in the treatment of Schizophrenia
路亚洲 1白羽霞 2李虹耀 2韩晟2
作者信息
- 1. 首都医科大学附属北京安定医院，北京 100000
- 2. 北京大学药学院，北京 100000
- 折叠
摘要
Abstract
Objective Based on real world data, this study explores disease burden of schizophrenia and evaluates the impacts of quetiapine and olanzapine on economic burden.Methods Included data were extracted from urban basic medical insurance database.Then statistical analyses were used to analyze the data.Results Study included 26 patients with schizophrenia hospitalized patients,the average hospitalization time (116±56)d,average hospital- lization expenses for (8899±11,748) yuan.Quetiapine group patients hospitalization time was significantly lower than that in the olanzapine group,average hospitalization expenses and average daily hospitalization expenses were significantly lower than those of olanzapine group,average and daily drug cost,drug accounted for were significantly lower than the olanzapine group,differences were statisticaly significant(P<0.05).Conclusion Our mental division patients in hospital for a long time,burden of disease.Compared to the olanzapine,quetiapine can save medical resources and quetiapine economy better.关键词
精神分裂症/喹硫平/奥氮平/疾病负担Key words
Schizophrenia/Quetiapine/Olanzapine/Disease burden分类
临床医学引用本文复制引用
路亚洲,白羽霞,李虹耀,韩晟..喹硫平与奥氮平治疗精神分裂症患者的疾病负担研究[J].中国药物经济学,2016,11(7):10-13,4.
